Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Subclinical Inflammation and High Cardiovascular Risk
Clinical trial NCT02164578 · COMPLETED
Trial details
- NCT number
- NCT02164578
- Sponsor
- GWT-TUD GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2018-12-12
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.